AUSTIN, Texas, May 03, 2017 -- Jones Energy, Inc. (NYSE:JONE) (“Jones Energy” or “the Company”) has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (“SEC”) to allow for the potential resale of up to 181,600 shares of the Company’s 8.0% Series A Perpetual Convertible Preferred Stock (“Preferred Shares”) by affiliates of Metalmark Capital Partners (“Metalmark”) and up to 17,868,330 shares of the Company’s Class A Common Stock ("Class A Shares") by affiliates of JVL Advisors L.L.C (“JVL”). The filing of such registration statement satisfies the Company’s contractual obligation to register the Preferred Shares and the Class A Shares pursuant to an existing registration rights agreement entered into with Metalmark and JVL. The Company will not receive any proceeds from the sale of Class A Shares by JVL or Preferred Shares by Metalmark.
A registration statement relating to the Preferred Shares and the Class A Shares has been filed with the SEC. None of the Preferred Shares or the Class A Shares may be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Preferred Shares or the Class A Shares in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Jones Energy
Jones Energy, Inc. is an independent oil and natural gas company engaged in the development and acquisition of oil and natural gas properties in the Anadarko and Arkoma basins of Texas and Oklahoma. Additional information about Jones Energy may be found on the Company’s website at: www.jonesenergy.com.
Investor Contact: Page Portas, 512-493-4834 Investor Relations Associate Or Robert Brooks, 512-328-2953 Executive Vice President & CFO [email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



